Cambrex Applies to Bulk-Produce Controlled Drugs
Published Date: 9/14/2026
Notice
Summary
Cambrex High Point, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-18597, Craig Cohen, DPM; Decision and Order
2026-18604, Joseph John Stubbers III, D.O.; Decision and Order
Dr. Joseph John Stubbers III from Ohio lost his DEA registration to handle controlled substances because he no longer has the legal authority to prescribe them in Ohio. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of February 28, 2026. This means he can’t legally prescribe or manage controlled drugs anymore, impacting his medical practice and patients.
2026-18599, Cheryl White, N.P.; Decision and Order
2026-18605, Emran Mohammad, RN, APRN, CNP; Decision and Order
Previous / Next Documents
Previous: 2026-18751, Rescission Notice; West Fork Battle Creek Watershed Plan, Carbon County, Wyoming
The NRCS Wyoming State Office, in coordination with the U.S. Forest Service and the U.S. Army Corps of Engineers (USACE), is rescinding the notice of intent (NOI) to prepare an Environmental Impact Statement (EIS) for the West Fork Battle Creek Watershed Project in Carbon County, Wyoming, which was published in the Federal Register on December 28, 2022. NRCS has determined that the NOI was issued prior to confirming viable alternatives and need for an EIS.
Next: 2026-18754, Request for Information on Test Methods for Evaluating Solid Waste (SW-846), Waste Sampling and Toxicity Characteristic Leaching Procedure (TCLP) Testing
EPA updates test methods and waste sampling guidance as part of routine updates according to the Resource Conservation and Recovery Act (RCRA). To aid in the implementation of these directives, the Office of Resource Conservation and Recovery (ORCR) within the Environmental Protection Agency (EPA) requests information on SW-846 method experiences, needs, and requirements. ORCR is specifically interested in information on the Toxicity Characteristic Leaching Procedure (TCLP) Method 1311, including method challenges, and alternatives. Information is welcome from stakeholders involved in requesting, performing, and evaluating the results from SW-846 methods including, but not limited to, industry stakeholders, researchers, academia, state, Tribal, and local governments. This includes U.S. territories and the District of Columbia, other federal agencies, community groups, non-governmental organizations, the public, and international organizations. The EPA will use the information received in response to this request for information (RFI) to inform what action, if any, it may take.